Medicare Enrolled
Dr. Amarnath Vedere, MD
Cardiovascular Disease · Wellington, FL
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vedere from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vedere? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vedere
Dr. Amarnath Vedere is a cardiovascular disease in Wellington, FL, with 20 years in practice. Based on federal Medicare data, Dr. Vedere performed 6,118 Medicare services across 3,728 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vedere received a total of $17,739 from 41 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vedere is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 16% volume in FL$ $17,739 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,118
Medicare services
Top 16% in FL for cardiovascular disease
3,728
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~306 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 1,170 | $66 | $158 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 651 | $88 | $236 |
| Regadenoson injection (Lexiscan) for heart stress test | 428 | $43 | $100 |
| Echocardiogram, transthoracic | 360 | $146 | $429 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 332 | $49 | $159 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 326 | $342 | $1,014 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 285 | $29 | $74 |
| Remote pacemaker/defibrillator monitoring, 90 days | 282 | $17 | $53 |
| Remote pacemaker monitoring, 90 days | 235 | $22 | $67 |
| Electrocardiogram (EKG), 12-lead | 206 | $10 | $36 |
| Office visit, established patient (10-19 min) | 191 | $40 | $96 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 184 | $20 | $59 |
| New patient office visit (45-59 min) | 182 | $119 | $348 |
| Hospital follow-up visit, high complexity | 156 | $96 | $220 |
| Initial hospital admission, high complexity | 146 | $138 | $430 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 143 | $51 | $183 |
| Office visit, established patient (30-39 min) | 138 | $85 | $228 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 108 | $18 | $48 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 102 | $20 | $59 |
| Cardiac catheterization | 66 | $219 | $639 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 62 | $0 | $108 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 52 | $20 | $58 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 51 | $647 | $1,445 |
| Ultrasound of both sides of head and neck blood flow | 51 | $150 | $414 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 47 | $29 | $82 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $140 | $405 |
| Programming of dual lead pacemaker system | 29 | $58 | $149 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $399 | $1,207 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $10 | $105 |
| Ultrasound of leg arteries or artery grafts | 18 | $148 | $477 |
| Coronary stent placement | 14 | $478 | $1,347 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $132 | $392 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.5% high complexity
20.6% medium
61.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,739
Total received (2018-2024)
Avg $2,534/year across 7 years
Top 15% in FL for cardiovascular disease
41
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,669 (60.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,070 (39.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$859
2023$1,086
2022$1,061
2021$692
2020$484
2019$3,602
2018$9,955
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Cardiovascular Systems Inc.
$7,004
Medtronic Vascular, Inc.
$3,536
Janssen Pharmaceuticals, Inc
$1,686
Bard Peripheral Vascular, Inc.
$1,006
E.R. Squibb & Sons, L.L.C.
$555
Boehringer Ingelheim Pharmaceuticals, Inc.
$441
Novartis Pharmaceuticals Corporation
$439
Amgen Inc.
$401
Abbott Laboratories
$317
Boston Scientific Corporation
$282
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$259
ShockWave Medical, Inc
$196
CARDIVA MEDICAL, INC.
$161
CVRx, Inc.
$146
Bolton Medical Inc
$133
Philips Electronics North America Corporation
$133
AstraZeneca Pharmaceuticals LP
$130
Astellas Pharma US Inc
$118
Amarin Pharma Inc.
$107
PFIZER INC.
$96
AtriCure, Inc.
$77
BIOTRONIK INC.
$63
Esperion Therapeutics, Inc.
$56
Medtronic, Inc.
$47
Kiniksa Pharmaceuticals, Ltd.
$45
SANOFI-AVENTIS U.S. LLC
$35
ATRICURE, INC.
$27
Chiesi USA, Inc.
$27
KVK-Tech, Inc.
$25
Merck Sharp & Dohme LLC
$25
Allergan Inc.
$21
CORDIS US CORP.
$20
Inspire Medical Systems, Inc.
$18
GENZYME CORPORATION
$17
Novo Nordisk Inc
$16
Edwards Lifesciences Corporation
$16
Cardinal Health 200 LLC
$14
Merck Sharp & Dohme Corporation
$14
G Medical Diagnostic Services, Inc.
$12
Cook Medical LLC
$11
ACIST MEDICAL SYSTEMS, INC.
$9
Top 3 companies account for 68.9% of total payments
Associated products mentioned in payments ›
AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Allure Quadra RF CRT Pacemaker · Amplia MRI · Arcalyst · Assurity Pacemaker · AtriCure AtriClip LAA Exclusion System · AtriCure Synergy Ablation System · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · COOK MEDICAL MICROPUNCTURE · CVI SYSTEMS · Cardiac Monitoring Suite · CareLink · ClosureFast · Corlanor · Coronary Orbital Atherectomy System · Diamondback Peripheral · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Endurity Pacemaker · Evera · FARXIGA · General - Therapies · IGT D Peripheral · INSPIRE · Integrity · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LifeVest · MULTAQ · Micra · MitraClip System · MyCareLink Smart · NC TREK NEO · NEXLETOL · Ozempic · PRADAXA · Percepta · Peripheral Orbital Atherectomy System · RESOLUTE ONYX · Relay Plus · Repatha · Resolute · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · STABILIZER · Stellarex Long · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · VenaSeal · Venclose Maven Catheter · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $290 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
185
Per 100K population
12.3
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vedere is a cardiac & remote specialist, with above-average Medicare volume (top 16% in FL), and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vedere experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Vedere performed 1,170 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vedere receive payments from pharmaceutical companies?
Yes. Dr. Vedere received a total of $17,739 from 41 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vedere's costs compare to other cardiovascular diseases in Wellington?
Dr. Vedere's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vedere) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Wellington
Browse cardiovascular diseases in Wellington ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology